After This Week’s -10.34% Loss In Windtree Therapeutics Inc (NASDAQ: WINT), We Just Learned Something New

Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares stood at 0.33 million during the latest session, with the company’s beta value hitting 0.50. At the last check today, the stock’s price was $0.34, to imply a decrease of -15.32% or -$0.06 in intraday trading. The WINT share’s 52-week high remains $11.98, putting it -3423.53% down since that peak but still an impressive 17.65% since price per share fell to its 52-week low of $0.28. The company has a valuation of $3.12M, with an average of 199.15K shares over the past 3 months.

Windtree Therapeutics Inc (NASDAQ:WINT) trade information

After registering a -15.32% downside in the latest session, Windtree Therapeutics Inc (WINT) has traded red over the past five days. The stock hit a weekly high of 0.4831, dropping -15.32% in its intraday price action. The 5-day price performance for the stock is -10.34%, and -2.91% over 30 days. With these gigs, the year-to-date price performance is -52.74%.

Windtree Therapeutics Inc (WINT) estimates and forecasts

Looking at statistics comparing Windtree Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Windtree Therapeutics Inc (WINT) shares are -74.83% down over the last 6 months, with its year-to-date growth rate higher than industry average at 73.47% against 13.10%.

Revenue forecast for the current quarter as set by 1 analysts is -$. Meanwhile, for the quarter ending Jun 2024, a total of 1 analyst(s) estimate revenue growth to -$.Earnings reports from the last fiscal year show that sales brought in -$ and -$ respectively in the corresponding quarters.

WINT Dividends

Windtree Therapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Windtree Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.